Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Device Evaluation of CONTAK(R) RENEWAL 2/4/4HE and EASYTRAK(R) 2: Assessment of Safety and Effectiveness in Heart Failure (DECREASE-HF)

NCT00158951 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.

NCT NCT00158951
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00158951 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Device Evaluation of CONTAK(R) RENEWAL 2/4/4HE and EASYTRAK(R) 2: Assessment of Safety and Effectiveness in Heart Failure (DECREASE-HF)
Lead sponsor
Boston Scientific Corporation
Phase
Phase 2/3
Overall status
Completed
Start date
March 31, 2003
Completion date
October 31, 2004
Enrollment
360
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

congestive heart failure